Shuttle Net Tangible Assets vs Net Receivables Analysis
| SHPH Stock | USD 0.42 0.01 2.00% |
Shuttle Pharmaceuticals financial indicator trend analysis is much more than just breaking down Shuttle Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shuttle Pharmaceuticals is a good investment. Please check the relationship between Shuttle Pharmaceuticals Net Tangible Assets and its Net Receivables accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.
Net Tangible Assets vs Net Receivables
Net Tangible Assets vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shuttle Pharmaceuticals Net Tangible Assets account and Net Receivables. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Shuttle Pharmaceuticals' Net Tangible Assets and Net Receivables is -0.48. Overlapping area represents the amount of variation of Net Tangible Assets that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Shuttle Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Shuttle Pharmaceuticals' Net Tangible Assets and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Tangible Assets of Shuttle Pharmaceuticals are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Net Tangible Assets i.e., Shuttle Pharmaceuticals' Net Tangible Assets and Net Receivables go up and down completely randomly.
Correlation Coefficient | -0.48 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Net Tangible Assets
The total assets of a company minus any intangible assets such as patents, copyrights, and goodwill; it represents the physical assets of a company.Net Receivables
Most indicators from Shuttle Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shuttle Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.As of now, Shuttle Pharmaceuticals' Selling General Administrative is increasing as compared to previous years. The Shuttle Pharmaceuticals' current Enterprise Value Over EBITDA is estimated to increase to 0.04, while Issuance Of Capital Stock is projected to decrease to under 3.8 M.
| 2022 | 2023 | 2024 | 2025 (projected) | |
| Total Operating Expenses | 2.6M | 5.9M | 7.7B | 8.1B |
| Cost Of Revenue | 66.8K | 6.8K | 6.1K | 5.8K |
Shuttle Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Shuttle Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Currently Active Assets on Macroaxis
When determining whether Shuttle Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Shuttle Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Shuttle Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Shuttle Pharmaceuticals Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Shuttle Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in Shuttle Stock please use our How to Invest in Shuttle Pharmaceuticals guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Shuttle Pharmaceuticals. If investors know Shuttle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Shuttle Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Shuttle Pharmaceuticals is measured differently than its book value, which is the value of Shuttle that is recorded on the company's balance sheet. Investors also form their own opinion of Shuttle Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Shuttle Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Shuttle Pharmaceuticals' market value can be influenced by many factors that don't directly affect Shuttle Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Shuttle Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Shuttle Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Shuttle Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.